CSL

CSL Limited is also considered one of the largest companies in Australia. It is a worldwide specialty biotechnology firm based in Australia that conducts research, develops, produces, and promotes goods for the diagnosis, treatment, and avoidance of serious human medical illnesses. It offers the product categories such as plasma derivatives, vaccinations, antivenoms, and cell culture reagents. These items are employed in several medical and genetic research and industry applications.

The company was established in 1916 as Commonwealth Serum Laboratories, and up until it was privatized in 1994, the Australian federal government controlled 100 percent of it. Since its founding, with a passionate global presence, CSL has constantly innovated from developing life-saving and life-improving treatments to developing vaccines that protect human beings.

CSL concentrates on and exhibits global leadership in three different fields: nephrology and iron deficiency, uncommon and dangerous illnesses, and influenza vaccinations. In terms of rare and serious diseases, CSL Behring develops novel therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological condition, which are utilized all over the world. In addition, through its influenza vaccine business, CSL Seqirus is a major contributor to influenza prevention and control, as well as a partner in global pandemic preparedness. With expertise in iron deficiency and anemia caused by heart failure, body disease, digestive disease, and inflammatory bowel disease, CSL Vifor also helps patients affected by these conditions lead better, healthier lives.

Founded: 1916
Headquarters: Parkville, Melbourne, Victoria, Australia

Website: https://www.csl.com/